| Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A–dependent phospho-Akt inactivation in estrogen receptor–negative human breast cancer cells CY Liu, MH Hung, DS Wang, PY Chu, JC Su, TH Teng, CT Huang, ... Breast cancer research 16, 1-15, 2014 | 123 | 2014 |
| A genetically encoded, phage‐displayed cyclic‐peptide library XS Wang, PHC Chen, JT Hampton, JM Tharp, CA Reed, SK Das, ... Angewandte Chemie 131 (44), 16051-16056, 2019 | 83 | 2019 |
| Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells CY Liu, MH Hu, CJ Hsu, CT Huang, DS Wang, WC Tsai, YT Chen, ... Oncotarget 7 (8), 9135, 2016 | 55 | 2016 |
| EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells CY Liu, TT Huang, CT Huang, MH Hu, DS Wang, WL Wang, WC Tsai, ... European journal of cancer 72, 112-123, 2017 | 39 | 2017 |
| Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells CY Liu, JC Su, MH Ni, LM Tseng, PY Chu, DS Wang, WT Tai, YP Kao, ... Breast cancer research and treatment 146, 71-84, 2014 | 21 | 2014 |
| Allosteric modulation of small molecule drugs on ACE2 conformational change upon binding to SARS-CoV-2 spike protein DS Wang, HS Hayatshahi, VM Jayasinghe-Arachchige, J Liu 2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM …, 2021 | 5 | 2021 |
| Correction: Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells CY Liu, MH Hu, CJ Hsu, CT Huang, DS Wang, WC Tsai, YT Chen, ... Oncotarget 8 (6), 10760, 2017 | 4 | 2017 |
| CIP2A mediates the effect of tamoxifen-induced apoptosis in estrogen receptor negative breast cancer cells. LM Tseng, CY Liu, KC Chang, DS Wang, CW Shiau, KF Chen Cancer Research 73 (8_Supplement), 914-914, 2013 | 2 | 2013 |
| A Mechanism study toward understanding the protective effects of glutaredoxin 2 (Grx2) on light-induced retinal damage DS Wang, X Liu, C Xavier, P Ananti, Y Liu, H Wu | 1 | 2018 |
| Prediction of Ligand Selectivity and Efficacy Using Artificial Intelligence Algorithms E Mathew, DS Wang, K Liu, T Pham, SS Madugula, K Emmitte, J Liu | | 2023 |
| Development of a Machine Learning Model to Design Target-specific Ligands E Mathew, J Liu, DS Wang, K Liu | | 2022 |
| Optimization of CRISPR-Cas9 via the synergy of MD simulation and machine learning J Liu, DS Wang, I Liang | | 2021 |
